Episode 50

Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR

Featuring perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics:

  • Introduction: Relative Impact of Targeted Treatment (00:00)
  • HER2 Alterations (8:04)
  • KRAS Mutations (24:25)
  • MET Overexpression (30:34)
  • ALK Fusions (32:34)
  • ROS1 Fusions (42:36)
  • RET Fusions (52:00)

CME information and select publications

All Episodes Previous Episode

About the Podcast

Show artwork for Lung Cancer Update
Lung Cancer Update
This series bridges the gap between research and patient care by providing medical oncologists and hematologists ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Listen for free